Stay updated on Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s footer/version indicator was updated from Revision v3.5.2 to v3.5.3. Additional non-core resource labeling (e.g., a genetics/rare diseases resource entry and “Idiopathic Pulmonary Fibrosis” resource section) was added/clarified.SummaryDifference0.3%

- Check19 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedRemoved references to Interstitial lung disease 2 and the Genetic and Rare Diseases Information Center under Resources.SummaryDifference0.2%

- Check47 days agoChange Detected- Revision updated to v3.5.0 (replacing v3.4.3).SummaryDifference0.1%

- Check54 days agoChange DetectedFooter now shows Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision history updated: added Revision: v3.4.2 and removed Revision: v3.4.1. This is a minor metadata update to the page.SummaryDifference0.1%

Stay in the know with updates to Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page.